BLOOMINGTON, Minn., Feb. 16, 2017 -- MatrixCare®, the largest U.S. LTPAC technology provider, today announced the appointment of Stephen Pacicco as Senior Vice President, Corporate Development, effective immediately. Pacicco serves as a member of MatrixCare’s executive team and has full responsibility for MatrixCare’s corporate development efforts. He reports to MatrixCare President and CEO John Damgaard.
“MatrixCare is proud to have recently been recognized as 2017 Best in KLAS for long-term care software and continues to experience strong growth across the LTPAC spectrum of care as we work to equip providers for success in a fee-for-value healthcare system,” Damgaard said. “I am pleased to add Steve to our industry-best leadership team and I look forward to his contributions in leading our accelerating corporate development efforts. We are beginning to see the LTPAC HIT landscape converge and our pipeline of potential acquisitions is quickly expanding. Our rock-solid financial profile and cash-generating performance differentiates us from our traditional competition, putting us in an enviable position to further accelerate our growth. We are now very pleased to have a proven senior executive of Steve’s caliber to lead us in capitalizing on these opportunities.”
Prior to joining MatrixCare, Pacicco served as CEO and director of SigmaCare from 2006 to 2016, leading the business through substantial growth and expansion. Prior to SigmaCare, Pacicco served in various executive capacities with Amicore and Pfizer. Pacicco holds an MBA with Honors from Columbia University and a BS in Chemical Engineering from Lehigh University.
Current and prospective clients and partners will have the chance to meet Pacicco at the 2017 HIMSS conference beginning February 19th in Orlando.
About MatrixCare
MatrixCare solutions have powered the long term care continuum for over 30 years. MatrixCare is the largest U.S. LTPAC technology provider and the first to offer a true full-spectrum solution. Used in more than 12,000 facility-based care settings and 2,000 home care and home health agencies, MatrixCare’s solutions help skilled nursing and senior living providers, life plan communities (CCRCs), and home health organizations to prosper as we migrate to a fee-for-value healthcare system. Through our Microsoft Azure-powered CareCommunity Population Care Management platform, we are also able to offer the industry’s first solution for helping the emerging set of conveners and diversified LTPAC operators to deliver superior care and better outcomes across the full spectrum of care. Visit www.matrixcare.com and www.carecommunity.com for more information.
MatrixCare is a registered trademark of MatrixCare.
Contact: Mary Beth Mohn Vice President of Marketing (952) 995-9904 [email protected]


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



